Mereo BioPharma Group plc (NASDAQ:MREO – Get Rating)’s share price rose 8.7% during mid-day trading on Monday . The stock traded as high as $1.29 and last traded at $1.25. Approximately 2,851,599 shares traded hands during mid-day trading, an increase of 157% from the average daily volume of 1,111,684 shares. The stock had previously closed […]
Mereo BioPharma Group (NASDAQ:MREO – Get Rating) and Sage Therapeutics (NASDAQ:SAGE – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Earnings & Valuation This table compares Mereo BioPharma Group […]
Needham & Company LLC reiterated their buy rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Get Rating) in a report released on Friday morning, Benzinga reports. They currently have a $5.00 price objective on the stock. Mereo BioPharma Group Stock Performance Shares of NASDAQ:MREO opened at $0.99 on Friday. Mereo BioPharma Group has a […]
Needham & Company LLC restated their buy rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Get Rating) in a report released on Friday, Benzinga reports. Needham & Company LLC currently has a $5.00 price target on the stock. Mereo BioPharma Group Stock Performance Shares of MREO opened at $1.00 on Friday. Mereo BioPharma Group […]
Mereo BioPharma Group (NASDAQ:MREO – Get Rating)‘s stock had its “buy” rating reiterated by equities researchers at Needham & Company LLC in a research note issued to investors on Friday, Benzinga reports. They presently have a $5.00 price target on the stock. Needham & Company LLC’s price target indicates a potential upside of 405.10% from […]